Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.68 USD | +1.45% | +17.68% | +30.09% |
07:25pm | Cogent Biosciences Q1 Loss Widens | MT |
02:26pm | Cogent Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.09% | 724M | |
+9.34% | 106B | |
+0.57% | 104B | |
+6.72% | 23.25B | |
-13.63% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-11.99% | 16.99B | |
+8.42% | 14.26B | |
+38.06% | 12.76B |
- Stock Market
- Equities
- COGT Stock
- News Cogent Biosciences, Inc.
- Wedbush Raises Cogent Biosciences' PT to $10 From $5, Adjusts Peak Penetration Assumptions for Bezuclastinib in Systemic Mastocytosis; Keeps Neutral Rating